1950-36-3
1950-36-3
Chemical Structure
Leyk
- CAS No.: 1950-36-3
- Formula:C14H17NO4S
- Molecular Weight:295.35
IUPAC Name: 2-(2-ethoxy-2-oxo-1-phenylethyl)thiazolidine-4-carboxylic acid
InChIKey: XDBMTQVSHNQIFU-UHFFFAOYSA-N
SMILES: O=C(C1NC(C(C2=CC=CC=C2)C(OCC)=O)SC1)O
Biological Activity: Leyk is an orally active Cysteine derivative. Leyk stimulates bone marrow hematopoiesis. Leyk exerts a significant protective effect against cyclophosphamide-induced leukopenia. Leyk can be used in studies related to thrombocytopenia and leukopenia[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Leyk | 99.99% | Leyk is an orally active Cysteine derivative. Leyk stimulates bone marrow hematopoiesis. Leyk exerts a significant protective effect against cyclophosphamide-induced leukopenia. Leyk can be used in studies related to thrombocytopenia and leukopenia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Su M, et al. The therapeutic effect of leucogen in treating alcoholic liver cirrhosis with thrombocytopenia or leukopenia. Ann Saudi Med. 2025;45(1):9-17. [Content Brief]
- [2]. Huang XE, et al. Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia. Asian Pac J Cancer Prev. 2014;15(19):8495-8497. [Content Brief]
- [3]. Tian S, et al. Systems Biology Analysis of the Effect and Mechanism of Qi-Jing-Sheng-Bai Granule on Leucopenia in Mice. Front Pharmacol. 2019 Apr 25;10:408. [Content Brief]
